Variant report
Variant | esv3408844 |
---|---|
Chromosome Location | chr12:104607310-104607778 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:52)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | EP300 | chr12:104607719-104608272 | SK-N-SH_RA | brain: | n/a | n/a |
2 | EP300 | chr12:104607628-104608286 | SK-N-SH | brain: | n/a | n/a |
3 | EP300 | chr12:104607661-104607960 | T-47D | breast: | n/a | n/a |
4 | EP300 | chr12:104607734-104608242 | SK-N-SH_RA | brain: | n/a | n/a |
5 | EP300 | chr12:104607630-104608104 | T-47D | breast: | n/a | n/a |
6 | EP300 | chr12:104607550-104608143 | A549 | lung: | n/a | n/a |
7 | EP300 | chr12:104607549-104608283 | A549 | lung: | n/a | n/a |
8 | ESR1 | chr12:104607662-104607972 | T-47D | breast: | n/a | n/a |
9 | ESR1 | chr12:104607614-104608002 | T-47D | breast: | n/a | n/a |
10 | ESR1 | chr12:104607644-104608057 | T-47D | breast: | n/a | n/a |
11 | ESR1 | chr12:104607703-104607988 | T-47D | breast: | n/a | n/a |
12 | FOSL2 | chr12:104607558-104608362 | A549 | lung: | n/a | n/a |
13 | FOSL2 | chr12:104607718-104608254 | SK-N-SH | brain: | n/a | n/a |
14 | FOXA1 | chr12:104607644-104607937 | HepG2 | liver: | n/a | chr12:104607741-104607753 chr12:104607761-104607773 |
15 | FOXA1 | chr12:104607702-104608014 | T-47D | breast: | n/a | chr12:104607741-104607753 chr12:104607761-104607773 |
16 | FOXA1 | chr12:104607546-104608017 | T-47D | breast: | n/a | chr12:104607741-104607753 chr12:104607761-104607773 |
17 | FOXA2 | chr12:104607486-104608174 | A549 | lung: | n/a | chr12:104607741-104607753 chr12:104607761-104607773 |
18 | FOXA2 | chr12:104607493-104608080 | A549 | lung: | n/a | chr12:104607741-104607753 chr12:104607761-104607773 |
19 | GATA3 | chr12:104607648-104608413 | SK-N-SH | brain: | n/a | n/a |
20 | GATA3 | chr12:104607642-104608130 | T-47D | breast: | n/a | n/a |
21 | GATA3 | chr12:104607552-104608198 | A549 | lung: | n/a | n/a |
22 | GATA3 | chr12:104607705-104608229 | SK-N-SH | brain: | n/a | n/a |
23 | JUND | chr12:104607663-104608119 | A549 | lung: | n/a | n/a |
24 | MAX | chr12:104607727-104608159 | SK-N-SH | brain: | n/a | n/a |
25 | MAX | chr12:104607741-104608140 | SK-N-SH | brain: | n/a | n/a |
26 | NFIC | chr12:104607662-104608326 | SK-N-SH | brain: | n/a | n/a |
27 | PBX3 | chr12:104607649-104608216 | SK-N-SH | brain: | n/a | n/a |
28 | PBX3 | chr12:104607698-104608339 | SK-N-SH | brain: | n/a | n/a |
29 | POLR2A | chr12:104607579-104608308 | PFSK-1 | brain: | n/a | n/a |
30 | POLR2A | chr12:104607712-104608039 | U87 | brain: | n/a | n/a |
31 | POLR2A | chr12:104607656-104608212 | SK-N-SH | brain: | n/a | n/a |
32 | POLR2A | chr12:104607603-104608153 | PANC-1 | pancreas: | n/a | n/a |
33 | POLR2A | chr12:104607749-104608142 | SK-N-SH | brain: | n/a | n/a |
34 | POLR2A | chr12:104607677-104608039 | U87 | brain: | n/a | n/a |
35 | POLR2A | chr12:104607561-104608156 | PANC-1 | pancreas: | n/a | n/a |
36 | RAD21 | chr12:104607732-104608090 | SK-N-SH_RA | brain: | n/a | n/a |
37 | RAD21 | chr12:104607727-104608100 | SK-N-SH_RA | brain: | n/a | n/a |
38 | RCOR1 | chr12:104607564-104608232 | IMR90 | lung: | n/a | n/a |
39 | REST | chr12:104607739-104608037 | PANC-1 | pancreas: | n/a | n/a |
40 | REST | chr12:104607545-104608145 | A549 | lung: | n/a | n/a |
41 | REST | chr12:104607775-104607998 | SK-N-SH | brain: | n/a | n/a |
42 | REST | chr12:104607638-104608121 | PFSK-1 | brain: | n/a | n/a |
43 | REST | chr12:104607675-104608078 | PFSK-1 | brain: | n/a | n/a |
44 | SIN3AK20 | chr12:104607726-104608024 | PFSK-1 | brain: | n/a | n/a |
45 | SIN3AK20 | chr12:104607763-104608107 | PFSK-1 | brain: | n/a | n/a |
46 | SP1 | chr12:104607564-104608334 | A549 | lung: | n/a | n/a |
47 | SP1 | chr12:104607540-104608232 | A549 | lung: | n/a | n/a |
48 | TCF12 | chr12:104607409-104608582 | A549 | lung: | n/a | chr12:104608377-104608387 |
49 | TCF12 | chr12:104607631-104608498 | SK-N-SH | brain: | n/a | chr12:104608377-104608387 |
50 | TCF12 | chr12:104607532-104608483 | SK-N-SH | brain: | n/a | chr12:104608377-104608387 |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:104606650..104611349-chr12:104679680..104683932,8 | K562 | blood: | |
2 | chr12:104606513..104608916-chr12:104687474..104689999,2 | K562 | blood: | |
3 | chr12:104605545..104609502-chr12:104611890..104614832,4 | MCF-7 | breast: | |
4 | chr12:104529918..104532327-chr12:104605294..104607957,2 | MCF-7 | breast: | |
5 | chr12:104606650..104616346-chr12:104679108..104687347,18 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
TXNRD1 | TF binding region |
ENSG00000198431 | chromatin interactions |
ENSG00000120837 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs371968657 | chr12:104607315-104607316 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs143714511 | chr12:104607364-104607365 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs199704504 | chr12:104607365-104607366 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs549583764 | chr12:104607367-104607368 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs560858826 | chr12:104607404-104607405 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs563973316 | chr12:104607414-104607415 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs182642346 | chr12:104607429-104607430 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs546042558 | chr12:104607432-104607433 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs141828340 | chr12:104607433-104607434 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs368103651 | chr12:104607438-104607439 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs537649827 | chr12:104607439-104607440 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs35724875 | chr12:104607453-104607454 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs187678048 | chr12:104607480-104607481 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs192726726 | chr12:104607538-104607539 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs72487512 | chr12:104607580-104607581 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs541567251 | chr12:104607581-104607582 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs532619210 | chr12:104607624-104607625 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
18 | rs552406984 | chr12:104607632-104607633 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs140747866 | chr12:104607633-104607634 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs184132972 | chr12:104607688-104607689 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs367625394 | chr12:104607709-104607710 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 16751803 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 16397240 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Neurocytoma | 17123091 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:104599200-104609200 | Weak transcription | Ovary | ovary |
2 | chr12:104602000-104609200 | Weak transcription | HSMM | muscle |
3 | chr12:104605200-104607800 | Weak transcription | NHDF-Ad | bronchial |
4 | chr12:104606400-104607800 | Enhancers | A549 | lung |
5 | chr12:104606600-104607400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
6 | chr12:104606800-104607800 | Weak transcription | Osteobl | bone |
7 | chr12:104607000-104609200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr12:104607400-104607800 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |